Raymond James & Associates Harvard Bioscience Inc Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$5.16 - $7.14 $175,532 - $242,888	-34,018 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$6.37 - $8.18 $216,694 - $278,267	34,018 New	34,018 $240,000
Q3 2021 Nov 02, 2021	SELL	$6.98 - $8.47 $235,693 - $286,006	-33,767 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.44 - $8.4 $183,692 - $283,642	33,767 New	33,767 $281,000
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $85,042 - $152,032	-21,750 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.0 - $4.5 $65,250 - $97,875	21,750 New	21,750 $93,000

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.